Palliative care in BMT

Bone Marrow Transplantation

Volumn 43, Issue 4, 2009, Pages 265-273

  Chung, H M ^a,b   Lyckholm, L J ^a   Smith, T J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; BENZODIAZEPINE DERIVATIVE; CALCINEURIN INHIBITOR; CALCIUM PHOSPHATE; DIPHENOXYLATE; FLUORIDE; GLUTAMINE; HALOPERIDOL; LOPERAMIDE; MORPHINE; OCTREOTIDE; OLANZAPINE; OPIATE; PALIFERMIN; PHENOTHIAZINE DERIVATIVE; PLACEBO; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; STEROID;

ACUPRESSURE; ANOREXIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CRYOTHERAPY; DIARRHEA; DOCTOR PATIENT RELATION; FAMILY ATTITUDE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HOSPICE CARE; HUMAN; MOUTH INFLAMMATION; NAUSEA; NAUSEA AND VOMITING; PAIN; PALLIATIVE THERAPY; PARENTERAL NUTRITION; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; TERMINAL CARE; WEIGHT REDUCTION;

BONE MARROW TRANSPLANTATION; HUMANS; PALLIATIVE CARE;

EID: 61449095468     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.436     Document Type: Review

References (85)

1. Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG et al NCCN Task Force Report. Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 2008; 6 (Suppl 1): S1-S21; quiz S22-S24.
2. Schmidt GM, Blume KG, Bross KJ, Spruce WE, Waldron JC, Levine R. Parenteral nutrition in bone marrow transplant recipients. Exp Hematol 1980; 8: 506-511.
3. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: A prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309-3316.
4. Weisdorf SA, Lysne J, Wind D, Haake RJ, Sharp HL, Goldman A et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987; 43: 833-838.
5. Ziegler TR. Glutamine supplementation in bone marrow transplantation. Br J Nutr 2002; 87 (Suppl 1): S9-S15.
6. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R et al Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992; 116: 821-828.
7. Coda BA, O'Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997; 72: 333-346.
8. Pillitteri LC, Clark RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 1998; 22: 495-498.
9. Zucker TP, Flesche CW, Germing U, Schroter S, Willers R, Wolf HH et al. Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation. Pain 1998; 75: 305-312.
10. Ganti AK, Lee SJ, Vose JM, Devetten MP, Bociek RG, Armitage JO et al Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. J Clin Oncol 2007; 25: 5643-5648.
11. Mander T. Haematology and palliative care: An account of shared care for a patient undergoing bone marrow transplantation for chronic myeloid leukaemia. Int J Nurs Pract 1997; 3: 62-66.
12. Kelly D, Ross S, Gray B, Smith P. Death, dying and emotional labour: problematic dimensions of the bone marrow transplant nursing role? J Adv Nurs 2000; 32: 952-960.
13. Yoon SJ, Conway J, McMillan M. An exploration of the concept of patient education: Implications for the development of educational programmes for relapsed post-bone marrow transplantation patients and their families in Korea. Int J Nurs Pract 2006; 12: 129-135.
14. Larson PJ, Viele CS, Coleman S, Dibble SL, Cebulski C. Comparison of perceived symptoms of patients undergoing bone marrow transplant and the nurses caring for them. Oncol Nurs Forum 1993; 20: 81-87; discussion 87-8.
15. Elsayem A, Swint K, Fisch MJ, Palmer JL, Reddy S, Walker P et al. Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol 2004; 22: 2008-2014.
16. Khatcheressian J, Cassel JB, Lyckholm L, Coyne P, Hagenmueller A, Smith TJ. Improving palliative and supportive care in cancer patients. Oncology (Williston Park) 2005; 19: 1365-1376; discussion 1377-1378, 1381-1382, 1384 passim.
17. Hill HF, Chapman CR, Kornell JA, Sullivan KM, Saeger LC, Benedetti C. Self-administration of morphine in bone marrow transplant patients reduces drug requirement. Pain 1990; 40: 121-129.
18. NMDP. www.marrow.org.
19. Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Semin Oncol 2003; 30 (6 Suppl 18): 76-83.
20. Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: Oral mucositis patient provider advisory board. Cancer Invest 2002; 20: 793-800.
21. Kushner JA, Lawrence HP, Shoval I, Kiss TL, Devins GM, Lee L et al Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale. J Can Dent Assoc 2008; 74: 59.
22. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590-2598.
23. Gabriel DA, Shea TC, Serody JS, Moore DT, Kirby SL, Harvey D et al Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies. Biol Blood Marrow Transplant 2005; 11: 1022-1030.
24. Papas AS, Clark RE, Martuscelli G, O'Loughlin KT, Johansen E, Miller KB. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31: 705-712.
25. Svanberg A, Birgegard G, Ohrn K. Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy - a randomized controlled trial. Support Care Cancer 2007; 15: 1155-1161.
26. Syrjala KL, Donaldson GW, Davis MW, Kippes ME, Carr JE. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: A controlled clinical trial. Pain 1995; 63: 189-198.
27. Lohr L. Chemotherapy-induced nausea and vomiting. Cancer J 2008; 14: 85-93.
28. Navari RM, Einhorn LH, Loehrer PJ S, Passik SD, Vinson J, McClean J et al. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier oncology group study. Support Care Cancer 2007; 15: 1285-1291.
29. Longo DL, Wesley M, Howser D, Hubbard SM, Anderson T, Young RC. Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesis. Cancer Treat Rep 1982; 66: 1975-1976.
30. Helson L. Total control of chemotherapy induced emesis. Anticancer Res 1992; 12: 2243-2244.
31. Findlay M, Simes RJ, Cox K, Carmichael K, Chey T, McNeil E et al. A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimen. Eur J Cancer 1993; 29A: 309-315.
32. Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Pierce HI, Flynn PJ et al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage 2003; 26: 731-742.
33. Sahler OJ, Hunter BC, Liesveld JL. The effect of using music therapy with relaxation imagery in the management of patients undergoing bone marrow transplantation: A pilot feasibility study. Altern Ther Health Med 2003; 9: 70-74.
34. Deng G, Cassileth BR, Yeung KS. Complementary therapies for cancer-related symptoms. J Support Oncol 2004; 2: 419-426; discussion 427-429.
35. Johansson JE, Abrahamsson H, Ekman T. Gastric emptying after autologous haemopoietic stem-cell transplantation: A prospective trial. Bone Marrow Transplant 2003; 32: 815-819.
36. Eagle DA, Gian V, Lauwers GY, Manivel JC, Moreb JS, Mastin S et al Gastroparesis following bone marrow transplantation. Bone Marrow Transplant 2001; 28: 59-62.
37. Maes BD, Vanwalleghem J, Kuypers D, Ghoos Y, Rutgeerts PJ, Vanrenterghem YF. Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. Transplantation 1999; 68: 1482-1485.
38. Nagula S, Schattner M. Malignant gastroparesis: Diagnostics and therapeutics. J Support Oncol 2007; 5: 366-367.
39. Weisdorf S, Ho.and C, Sharp HL, Teasley K, Schissel K, McGlave PB et al. Total parenteral nutrition in bone marrow transplantation: A clinical evaluation. J Pediatr Gastroenterol Nutr 1984; 3: 95-100.
40. Iestra JA, Fibbe WE, Zwinderman AH, van Staveren WA, Kromhout D. Body weight recovery, eating difficulties and compliance with dietary advice in the first year after stem cell transplantation: A prospective study. Bone Marrow Transplant 2002; 29: 417-424.
41. http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf.
42. Bianco JA, Higano C, Singer J, Appelbaum FR, McDonald GB. The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation. Transplantation 1990; 49: 1194-1195.
43. Alderman J. Fast Facts and Concepts #96 Diarrhea in palliative care (www.eperc.mcw.edu).
44. Cartoni C, Brunetti GA, D'Elia GM, Breccia M, Niscola P, Marini MG et al. Cost analysis of a domiciliary program of supportive and palliative care for patients with hematologic malignancies. Haematologica 2007; 92: 666-673.
45. Brown E, Bennett M. Survey of blood transfusion practice for palliative care patients in Yorkshire: Implications for clinical care. J Palliat Med 2007; 10: 919-922.
46. Koedoot CG, Oort FJ, de Haan RJ, Bakker PJ, de Graeff A, de Haes JC. The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are: palliative chemotherapy and watchful-waiting. Eur J Cancer 2004; 40: 225-235.
47. Sullivan AM, Lakoma MD, Matsuyama RK, Rosenblatt L, Arnold RM, Block SD. Diagnosing and discussing imminent death in the hospital: A secondary analysis of physician interviews. J Palliat Med 2007; 10: 882-893.
48. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300: 1665-1673.
49. Helft PR. Necessary collusion: Prognostic communication with advanced cancer patients. J Clin Oncol 2005; 23: 3146-3150.
50. Krasuska ME, Dmoszynska A, Daniluk J, Stanislawek A. Information needs of the patients undergoing bone marrow transplantation. Ann Univ Mariae Curie Sklodowska [Med] 2002; 57: 178-185.
51. Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC. Communication about prognosis between parents and physicians of children with cancer: Parent preferences and the impact of prognostic information. J Clin Oncol 2006; 24: 5265-5270.
52. Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC. Hope and prognostic disclosure. J Clin Oncol 2007; 25: 5636-5642.
53. Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 2006; 24: 3490-3496.
54. Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ. Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol 2006; 24: 4479-4484.
55. Lee SJ, Fairclough D, Antin JH, Weeks JC. Discrepancies between patient and physician estimates for the success of stem cell transplantation. JAMA 2001; 285: 1034-1038.
56. Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC. Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2003; 9: 389-396.
57. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D et al Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998; 279: 1709-1714.
58. Lamont EB, Siegler M. Paradoxes in cancer patients' advance care planning. J Palliat Med 2000; 3: 27-35.
59. Teno JM. Advance directives: Time to move on. Ann Intern Med 2004; 141: 159-160.
60. Esper P, Hampton JN, Finn J, Smith DC, Regiani S, Pienta KJ. A new concept in cancer care: The supportive care program. Am J Hosp Palliat Care 1999; 16: 713-722.
61. Pitorak EF. Care at the time of death. Am J Nurs 2003; 103: 42-52; quiz 53.
62. Bakitas M, Stevens M, Ahles T, Kirn M, Skalla K, Kane N et al. Project ENABLE: A palliative care demonstration project for advanced cancer patients in three settings. J Palliat Med 2004; 7: 363-372.
63. Wolfe J, Hammel JF, Edwards KE, Duncan J, Comeau M, Breyer J et al Easing of suffering in children with cancer at the end of life: Is care changing? J Clin Oncol 2008; 26: 1717-1723.
64. Zwerdling T, Hamann K, Meyers F. Extending palliative care is there a role for preventive medicine? J Palliat Med 2005; 8: 486-489.
65. Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR. Simultaneous care: A model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage 2004; 28: 548-556.
66. Ray A, Block SD, Friedlander RJ, Zhang B, Maciejewski PK, Prigerson HG. Peaceful awareness in patients with advanced cancer. J Palliat Med 2006; 9: 1359-1368.
67. Lesko LM. Bone marrow transplantation: Support of the patient and his/ her family. Support Care Cancer 1994; 2: 35-49.
68. Dobkin PL, Poirier RM, Bonny Y. Family factors affecting bone marrow transplantation. A case report. Psychother Psychosom 1995; 64 102-108.
69. Futterman AD, Wellisch DK, Zighelboim J, Luna-Raines M, Weiner H. Psychological and immunological reactions of family members to patients undergoing bone marrow transplantation. Psychosom Med 1996; 58 472-480.
70. Siston AK, List MA, Daugherty CK, Banik DM, Menke C, Cornetta K et al Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 27: 1181-1188.
71. Grimm PM, Zawacki KL, Mock V, Krumm S, Frink BB. Caregiver responses and needs. An ambulatory bone marrow transplant model. Cancer Pract 2000; 8: 120-128.
72. Packman W. Psychosocial impact of pediatric BMT on siblings. Bone Marrow Transplant 1999; 24: 701-706.
73. Wolfe J, Klar N, Grier HE, Duncan J, Salem-Schatz S, Emanuel EJ et al Understanding of prognosis among parents of children who died of cancer: Impact on treatment goals and integration of palliative care. JAMA 2000; 284: 2469-2475.
74. Higginson I, Wade A, McCarthy M. Palliative care: Views of patients and their families. BMJ 1990; 301: 277-281.
75. Meystre CJ, Burley NM, Ahmedzai S. What investigations and procedures do patients in hospices want? Interview based survey of patients and their nurses. BMJ 1997; 315: 1202-1203.
76. Monti M, Castellani L, Berlusconi A, Cunietti E. Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit. J Pain Symptom Manage 1996; 12: 18-22.
77. Higginson IJ, Finlay I, Goodwin DM, Cook AM, Hood K, Edwards AG et al Do hospital-based palliative teams improve care for patients or families at the end of life? J Pain Symptom Manage 2002; 23: 96-106.
78. Higginson IJ, Finlay IG, Goodwin DM, Hood K, Edwards AG, Cook A et al Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manage 2003; 25: 150-168.
79. Hearn J, Higginson IJ. Do specialist palliative care teams improve outcomes for cancer patients? A systematic literature review. Palliat Med 1998; 12: 317-332.
80. Payne SK, Coyne P, Smith TJ. The health economics of palliative care. Oncology (Williston Park) 2002; 16: 801-808; discussion 808, 811-812.
81. Smith TJ, Coyne P, Cassel B, Penberthy L, Hopson A, Hager MA. A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs. J Palliat Med 2003; 6: 699-705.
82. Penrod JD, Deb P, Luhrs C, Dellenbaugh C, Zhu CW, Hochman T et al. Cost and utilization outcomes of patients receiving hospital-based palliative care consultation. J Palliat Med 2006; 9: 855-860.
83. Ciemins EL, Blum L, Nunley M, Lasher A, Newman JM. The economic and clinical impact of an inpatient palliative care consultation service: A multifaceted approach. J Palliat Med 2007; 10: 1347-1355.
84. Andorsky DJ, Loberiza FR, Lee SJ. Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation. Bone Marrow Transplant 2006; 37 889-895.
85. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19 357-368.